Association of rare human papillomavirus types with genital premalignant and malignant lesions

Journal of Infectious Diseases

Volumn 178, Issue 1, 1998, Pages 252-255

  Meyer, Thomas ^a   Arndt, Rüdiger ^c   Christophers, Enno ^c   Beckmann, Ernst Rudolf ^c   Schröder, Sören ^c   Gissmann, Lutz ^c   Stockfleth, Eggert ^b  

^a Inst Immunol   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; CANCER STAGING; CONDYLOMA; FEMALE; GENITAL TRACT CANCER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS TYPING; WART VIRUS;

EID: 0031869404     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517447     Document Type: Article

References (15)

1. Gissmann L. Human papillomaviruses and genital cancer. Semin Cancer Biol 1992;3:253-61.
2. zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol 1994;186:131-56.
3. McDougall JK. Immortalization and transformation of human cells by human papillomavirus. Curr Top Microbiol Immunol 1994;186:102-19.
4. Bernard HU, Chan SY, Manos MM, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994;170:1077-85.
5. de Villiers EM. Human pathogenic papillomavirus types: an update. Curr Top Microbiol Immunol 1994;186:1-12.
6. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) study group. J Natl Cancer Inst 1995;87:796-802.
7. Manos MM, Waldman J, Zhang TY, et al. Epidemiology and partial nucleotide sequence of four novel genital human papillomaviruses. J Infect Dis 1994;170:1096-9.
8. Galloway DA. Editorial: Navigating the descent into papillomavirus hell. J Infect Dis 1994;170:1075-6.
9. Meyer T, Arndt R, Stockfleth E, Flammann H, Wolf H, Reischl U. Strategy for typing human papillomaviruses by RFLP analysis of PCR products and subsequent hybridization with a generic probe. BioTechniques 1995;19:632-9.
10. Fisher SG, Benitez-Brebiesca L, Nindl I, et al. The association of human papillomavirus type 16 E6 and E7 antibodies with stage of cervical cancer. Gynecol Oncol 1996;61:73-8.
11. Karlsen F, Kalantari M, Jenkins A, et al. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol 1996;34:2095-100.
12. Kiviat NB, Koutsky LA, Critchlow CW, et al. Prevalence and cytologic manifestations of human papilloma virus (HPV) types 6, 11, 16, 18, 31, 33, 35, 42, 43, 44, 45, 51, 52, and 56 among 500 consecutive women. Int J Gynecol Pathol 1992;11:197-203.
13. de Roda Husman AM, Walboomers JMM, Meijer CJLM, et al. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes using polymerase chain reaction. Int J Cancer 1994;56:802-6.
14. Tawheed AR, Beaudenon S, Favre M, Orth G. Characterization of human papillomavirus type 66 from an invasive carcinoma of the uterine cervix. J Clin Microbiol 1991;29:2656-60.
15. Peyton CL, Wheeler CM. Identification of five novel human papillomavirus sequences in the New Mexico triethnic population. J Infect Dis 1994;170:1089-92.